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Abstract
The spindle checkpoint is a mitotic surveillance system which ensures equal segregation of
sister chromatids. It delays anaphase onset by inhibiting the action of the E3 ubiquitin ligase
known as the anaphase promoting complex or cyclosome (APC/C). Mad3/BubR1 is a key
component of the mitotic checkpoint complex (MCC) which binds and inhibits the APC/C
early in mitosis. Mps1Mph1 kinase is critical for checkpoint signalling and MCC-APC/C inhibi-
tion, yet few substrates have been identified. Here we identify Mad3 as a substrate of fission
yeast Mps1Mph1 kinase. We map and mutate phosphorylation sites in Mad3, producing
mutants that are targeted to kinetochores and assembled into MCC, yet display reduced
APC/C binding and are unable to maintain checkpoint arrests. We show biochemically that
Mad3 phospho-mimics are potent APC/C inhibitors in vitro, demonstrating that Mad3p mod-
ification can directly influence Cdc20Slp1-APC/C activity. This genetic dissection of APC/C
inhibition demonstrates that Mps1Mph1 kinase-dependent modifications of Mad3 and Mad2
act in a concerted manner to maintain spindle checkpoint arrests.
Author Summary
When cells divide they need to ensure that a complete copy of their genetic material is
transmitted to both daughter cells. Cells have evolved many controls to ensure that every
division is carried out with very high fidelity. The spindle checkpoint is one such control,
which acts as a surveillance system during mitosis. Defects in this checkpoint control lead
to unequal segregation of DNA/chromosomes, termed aneuploidy, which is responsible
for human birth defects and is very common in tumour cells.
The molecular components of the spindle checkpoint, identified initially through yeast
genetics, include several protein kinases. Surprisingly few of their substrates have been
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Introduction
Defects in chromosome segregation result in aneuploidy, which can lead to disease or cell
death [1,2,3]. Mitosis is an extremely complicated and well orchestrated stage of the cell cycle,
and many controls are employed to ensure its high fidelity. One of the major controls is the
spindle checkpoint which acts as a surveillance system monitoring kinetochore-microtubule
attachments. It delays anaphase onset until all sister-chromatid pairs are bi-oriented on the
mitotic spindle [4,5,6]. Anaphase onset is initiated by an E3 ubiquitin ligase, known as the ana-
phase promoting complex or cyclosome (APC/C), and its activating co-factor Cdc20Slp1 [7,8].
Cdc20Slp1-APC/C targets the separase inhibitor securin and the CDK1 activating subunit cyclin
B for destruction by the 26S proteasome [9,10,11]. Once securin is destroyed, cohesin is cleaved
and sister chromatids separate and segregate in anaphase [12].
The spindle checkpoint utilises several mechanisms to efficiently inhibit Cdc20Slp1-APC/C.
These include sequestration and phosphorylation of Cdc20Slp1 [13], formation of the
mitotic checkpoint complex (MCC) that typically consists of the spindle checkpoint proteins
Mad2, BubR1/Mad3, Bub3 and Cdc20Slp1 [14,15,16,17,18] and MCC binding to the APC/C
[19,20,21,22]. Spindle checkpoint components are highly conserved from yeast to humans, and
include theMAD (mitotic-arrest deficient) and the BUB (budding uninhibitied by benzimid-
azole) genes [23,24]. Spindle checkpoint kinases include Mps1Mph1, Bub1 and Aurora BArk1,
but their precise signalling roles remain far from clear [25,26,27,28].
S.pombeMph1 is a structural and functional homologue of S.cerevisiaeMps1, but it is nei-
ther required for spindle pole duplication nor essential for cell viability [29]. Homologues in
higher organisms have been shown to be essential for the spindle checkpoint and for efficient
chromosome segregation [30,31,32,33,34,35,36].
The fission yeast Mps1Mph1 substrates identified to date are KNL1Spc7 [37,38] and Mad2
[39]. KNL1Spc7 is an important Mps1Mph1 substrate at kinetochores, which when phosphory-
lated becomes the kinetochore binding site for the Bub1-Bub3 complex [37,38]. This role is
conserved in budding yeast and vertebrates [38,40,41,42], and structural studies have shown
that it is Bub3 that binds directly to the MELT motifs after they are phosphorylated by
Mps1Mph1 [43,44]. In budding yeast it has been shown that Mps1Mph1 kinase then phosphory-
lates kinetochore-bound Bub1 to enhance the recruitment of the Mad1-Mad2 complex [45],
but this remains to be confirmed in other systems. Thus Mps1Mph1 kinase has a key role in
assembling the checkpoint signalling scaffold (KNL1Spc7-Bub1-Mad1) at yeast kinetochores.
Additional substrates of Mps1Mph1 kinase have been identified, including spindle pole body
components [46,47], the Borealin component of the human chromosomal passenger complex
(CPC) [30], and the Dam1 [48] and Ndc80 [49] kinetochore proteins. Thus it is clear that
Mps1Mph1 kinase is a central player in mitotic regulation [27].
In a previous study we identified Mad2 as an Mps1Mph1 checkpoint substrate and described
themad2-S92A allele that displayed reduced MCC-APC/C binding and reduced ability to
maintain spindle checkpoint arrest [39]. Here we demonstrate that Mad3 is another important
checkpoint substrate for Mps1Mph1 kinase. Twelve in vivo phosphorylation sites were mapped
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in Mad3, probably due to the action of multiple protein kinases (CDK, Mph1 and Ark1) and
sixteen phospho-modifications were generated and mapped in vitro through the direct action
of Mps1Mph1 kinase. A series of phosphorylation site mutants were generated, and mutations
in the C-terminus of Mad3 were found to have impaired checkpoint function. These defects
were compounded in strains where themad3-C9A allele was combined withmad2-S92A.
Importantly, when C-terminal Mad3 phosphomimics were directly tested in vitro they were
found to be potent APC/C inhibitors. We propose that Mps1Mph1 kinase phosphorylates multi-
ple components of the fission yeast MCC to stabilise its interaction with the APC/C and
thereby maintain spindle checkpoint arrests.
Results
Mad3p is phosphorylated by Mps1Mph1 kinase
We previously reported that Mad2p is phosphorylated by Mps1Mph1 kinase, and that mutation
of Mad2p phosphorylation sites partially abrogated the spindle checkpoint [39]. However, the
checkpoint phenotype of Mps1Mph1 kinase-dead alleles was much stronger, indicating that
other relevant Mps1Mph1 substrates remain to be found. Whilst phosphorylation of KNL1Spc7
at kinetochores may account for some of this checkpoint function [37,38], there was still a
defect apparent in themps1Δ spc7-T12E strain where all the Mps1Mph1 sites in KNL1Spc7 had
been mutated to phosphomimic (Glutamate) residues [38], again arguing for additional
Mps1Mph1 substrates. The bub3Δ phenotype, where Bub1p, Mad3p, Mad1p and Mad2p all fail
to be recruited to kinetochores yet the checkpoint arrest remains robust, also argues against an
absolute requirement for checkpoint proteins to be recruited to KNL1Spc7 and kinetochores in
fission yeast [50,51,52]. In the absence of Mps1Mph1 kinase activity the mitotic checkpoint
complex (MCC) is not tightly associated with APC/C [39], so we tested whether fission yeast
Mad3p is also a substrate of Mps1Mph1 kinase.
First we analysed the in vivo dependence of Mad3p modification on Mps1Mph1 kinase. No
clear gel shifts were apparent for Mad3p on regular SDS-PAGE and so we employed 2D gel-
immunoblotting, comparing Mad3p modification in wild-type cells and cells lacking Mps1Mph1
kinase activity. Asmps1-kd cells are unable to checkpoint arrest [39] we compared Mad3p
modification after cells had been mitotically arrested through overexpression of Mad2p [53].
Fig 1A shows a clear charge-related shift for Mad3p isoforms in the two mitotic yeast extracts,
demonstrating that Mad3p is modified in an Mps1Mph1 -dependent manner in fission yeast
during mitosis. Next we carried out in vitroMps1Mph1 kinase assays using recombinant
Mad3-MBP as substrate (Fig 1B). These assays were analysed by mass-spectrometry, both with
and without phosphopeptide enrichment on titanium oxide beads (see Materials and Meth-
ods). Under these conditions, sixteen in vitroMps1Mph1 sites in Mad3p (see Fig 1C and S2 Fig
for spectra) were identified.
To confirm these are phosphorylation sites in vivo we purified checkpoint complexes (puri-
fying Mad3-TAP and Apc4-TAP) containing Mad3p from both cycling and checkpoint
arrested (nda3) fission yeast cells, and analysed them by MudPIT [54]. We were able to con-
firm that eight of the in vitroMps1Mph1 sites (S19,S31,S33,T64,T259,S276,T278,S279) are also
modified in Mad3p purified from yeast cells (in vivo). In addition, four other in vivo sites (T82,
S246, S251 and S289) were found in Mad3p, identifying modifications that are presumably
made by other protein kinases. Whilst we do not know the identity of the other Mad3p kinase
(s), we think it extremely likely that S289 is a CDK site and note that T82 fits the Aurora
(Ark1) consensus. Mutation of the CDK site alone had no detectable phenotype (see S3 Fig).
Several of the Mps1Mph1 sites are conserved in fission yeasts (see S1 Fig). Whilst none of the
Mps1Mph1 sites are particularly well conserved in other organisms, we think it noteworthy that
Mps1Mph1 Kinase Phosphorylates Mad3
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there are conserved clusters of Mps1Mph1 phosphorylatable residues flanking both of the
Mad3p KEN boxes and that seven of these clustered residues (S19,S31,S33,T259,S276,T278,
S279) were only modified in mitotic samples. The Mad3p phosphorylation sites that we identi-
fied are summarised in Fig 1C and S1B Fig.
Mad3p phosphorylation site mutants are checkpoint defective
To test the physiological relevance of these Mps1Mph1 dependent modifications, we constructed
mutations in Mad3p phosphorylation sites in various combinations, substituting serine and
threonine residues with non-phosphorylatable alanines (mad3-N9A,mad3-C9A andmad3-
18A –see S1A Fig for full fission yeast Mad3p alignments). In vitro kinase assays were per-
formed using Mps1Mph1 kinase and recombinant Mad3-MBP fusion proteins containing these
mutations (Fig 1D). Quantitation demonstrated that the N-terminal sites account for ~50% of
the in vitromodification and the C-terminal sites ~30%. Importantly, mutation of all 18 sites
reduced phosphorylation by ~80%, indicating that we have identified almost all of the in vitro
sites for Mps1Mph1 kinase.
These mutations were then tested in yeast, by replacing the endogenousmad3+ gene with
the mutant alleles. They had no effect on Mad3 protein targeting to kinetochores (Fig 2A) nor
lead to significant growth defects when grown on plates containing the anti-microtubule drug
benomyl (see S3 Fig). However, when we employed more sensitive assays for loss of spindle
checkpoint function significant defects became apparent. Themad3 alleles were tested for their
ability to checkpoint arrest cells containing kinetochore defects, by employing the tempera-
ture-sensitive nuf2-3 allele [55] at 32°C, where typically ~30% of cells should arrest with short
spindles after 4 hours (Fig 2B). This experiment demonstrates that whilst mutation of nine N-
terminal phosphorylation sites in Mad3p had no effect on the ability of cells to arrest in
response to kinetochore attachment defects, mutation of nine C-terminal sites reduced the effi-
ciency of the nuf2-3 arrest by ~40%. Mutating all eighteen sites to alanine made the arrest even
worse (~50% efficiency), but this further decrease is hard to interpret as it could partly be due
to the reduced stability of this mutant Mad3 protein. The levels of the mutant Mad3 proteins
were ~75% formad3-C9A but only ~20% formad3-18A, and others have shown that when
Mad3p falls below 30% of its normal level it can perturb the checkpoint [56]. We propose that
phosphorylation of Mad3p, in particular towards its C-terminus, can enhance its ability to
maintain a checkpoint arrest and thereby delay anaphase onset. These results lead us to focus
on the C-terminal Mad3p phosphorylation sites for the rest of this study.
To confirm their checkpoint defect we challenged mitoticmad3-C9A cells growing in liquid
culture with the anti-microtubule drug carbendazim (CBZ) and analysed their rate of septation
(mitotic exit). Failure to maintain spindle checkpoint arrest leads to an increase in septation
index. We pre-synchronised cdc25 strains in G2 (growing them for 3.5 hrs at 36°C) and then
Fig 1. Mad3p phosphorylation. A. Mad3pmodification is Mps1Mph1-dependent. Wild-type andmph1-Δkinase strains expressing Mad3-TAPwere arrested in
mitosis by overproducing Mad2p (Mad2OP) from pREP1-Mad2. Yeast extracts were made, separated by 2D-PAGE and immunoblotted with peroxidase-
conjugated anti-peroxidase antibody to detect Mad3-TAP isoforms. B. Mps1Mph1 kinase phosphorylates Mad3p in vitro. Mps1Mph1-SZZ andMps1Mph1kinase-
dead-SZZ were purified from yeast extracts then used to phosphorylate Mad3-MBP or MBP. C. Mad3p phosphorylation sites. Mad3p schematic, highlighting
KEN boxes, the TPR region, and positions of the N9A and C9A alleles. Mass spectrometry identified many sites in Mad3p: those sites identified both in the in
vitroMps1Mph1 kinase assay and in vivo are highlighted in red. The 16th in vitroMps1Mph1 site (T195) is not labelled on this schematic. There is a putative Ark1
site in green (T82) and CDK site (S289) in blue. Alignments of Mad3p KEN box regions from the four sequenced fission yeasts (Sp Schizosaccharomyces
pombe, Soct Schizosaccharomyces octosporus, Sjap Schizosaccharomyces japonicus, Scry Schizosaccharomyces cryophilus–sequences available from the
Broad Institute, USA) highlighting clusters of phosphorylation sites flanking the KEN boxes. D. Mps1Mph1 kinase phosphorylates Mad3p alanine mutants at
reduced levels in vitro. The indicated recombinant Mad3-MBP fusion proteins were purified from bacteria and used as substrates in anMps1Mph1-SZZ kinase
assay. The kinase assay was performed 4 times, a representative coomassie gel and autoradiograph are shown here, and their quantitation plotted (mean with
SEM).
doi:10.1371/journal.pgen.1005834.g001
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released them (shifting down to 24°C) to undergo synchronous mitoses. Twenty minutes after
G2 release we added 75μg/ml CBZ to depolymerise their microtubules. Using this assay we
compared themad3-C9A allele with themad2-S92A andmps1-kd alleles we have previously
described [39]. Fig 2C shows that themad3-C9A cells fail to effectively maintain a checkpoint
arrest and septate with very similar kinetics tomad2-S92A. We made a double mutant
(mad3-C9A mad2-S92A) and found that these cells have a synthetic checkpoint defect and sep-
tate at a faster rate, in between that of the single mutants and themps1-kd allele (see S4A Fig
for representative images). We note that in some of these septating cells Mad3-GFP can still be
detected on kinetochores after cells have septated (see S4B Fig): this observation is consistent
with such cells having a downstream defect inmaintenance of their checkpoint arrest, rather
than a Mad3 defect in checkpoint signalling at kinetochores and/or their checkpoint being sat-
isfied due to proper kinetochore-microtubule attachments being formed.
The synthetic effect of the double mutant was also observed when the checkpoint was acti-
vated in the nda3mutant, with 33% ofmad3-C9A mad2-S92A cells unable to maintain a check-
point arrest after 8 hours (compared to 0.5% of wild type, 2% ofmad3-C9A and 11% of
mad2-S92A leaking through the arrest, Fig 2D). We conclude that reduced phosphorylation of
either Mad3p or Mad2p impairs maintenance of a checkpoint arrest, and that reduced phos-
phorylation of both proteins further reduces their ability to maintain a robust checkpoint
response. Our interpretation is that Mad3p and Mad2p are both phosphorylated by Mps1Mph1
kinase and that these modifications act in concert to inhibit Cdc20Slp1-APC/C.
Mad3p phosphorylation is important for MCC-APC/C binding
Next we wanted to analyse whether the phosphorylation of the Mad3p C-terminus was relevant
to MCC assembly and/or stabilisation. To do this, we carried out cdc25 (G2) block and release
time courses and monitored MCC assembly in themad3-C9A,mad2-S92A,mad3-C9A
mad2-S92A double mutants andmps1-kdmutants. Cdc20Slp1-pull downs, employing an inter-
nally-engineered 3xFLAG tag (see Materials and Methods) demonstrated that MCC was assem-
bled with normal kinetics inmad3-C9A andmad2-S92A alleles (Fig 3A), but that there were
slightly reduced MCC levels in the double mutant. We note that MCC levels dropped signifi-
cantly, by 70% compared to wild-type at 45 minutes, in themps1-kd strain (Fig 3B). Quantitation
of the Cdc20Slp1 protein levels in extracts through these time courses (see S6 Fig) shows that they
are only reduced in themps1-kdmutant, and there only by 20% which can not explain why the
MCC levels drop by 70–80% in this strain. No clear effect on mitotic progression was observed in
these unperturbed mitoses (Fig 3C), suggesting that it is not MCC levels that are rate-limiting.
We conclude that phosphorylation of neither the C-terminus of Mad3p nor of Mad2p are
critical for MCC assembly. Even when both Mad3p and Mad2p phosphorylation are impaired,
Fig 2. mad3 phospho-mutants are localised and assembled into MCC complexes effectively, butmad2mad3 double phospho-mutants have
severe defects in the maintenance of checkpoint arrests. A. Mutant Mad3 proteins are efficiently targeted to kinetochores. GFP fusions were constructed
for all three phospho-mutants and -KENmutants. cdc25 strains were synchronised in G2 and then released into mitosis for GFP imaging. Images shown
were taken 20 mins after release. DNA was stained with DAPI. The inset images are labelled with the % of cells having Mad3-GFP kinetochore foci. B. nuf2-3
strains containingmad3-N9A,mad3-C9A andmad3-18A alleles or themad2 non-dimerising mutant (M2 dimer) were shifted to 36°C for 4 hrs. Cells were
then fixed and microtubules were stained with anti-tubulin antibodies. The relative mitotic index (cells containing short metaphase spindles) is plotted after
normalising the % of mitotic spindles in the nuf2-3 control strain (which has a functional checkpoint) to 100. >100 cells were scored for each sample and this
experiment repeated 5 times (scatter dot plot: lines at mean with SD). C. cdc25 strains containingmad3-C9A,mad2-S92A,mad3-C9A andmad2-S92A, or
mps1mph1-kdmutations were synchronised in G2, released in mitosis and then challenged to arrest in response to the anti-microtubule drug carbendazim
(CBZ). Failure to maintain mitotic checkpoint arrest leads to septation and this was scored at 15 min time-intervals, by fixing cells and staining with calcofluor
(see supp. data for images). This experiment was repeated twice and >100 cells scored for each strain at each time point (plotted as mean with SEM). D.
nda3 strains containingmad3-C9A,mad2-S92A, ormad3-C9A andmad2-S92Amutations were grown to log phase and then shifted to 18°C to analyse their
ability to metaphase-arrest for several hours in response to the absence of microtubules. Failure to maintain arrest results in septation. This experiment was
repeated twice and 100 cells scored for each strain at each time point (plotted as mean with SEM).
doi:10.1371/journal.pgen.1005834.g002
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only slightly reduced MCC levels result (20–30% reduction in bound Mad2p relative to wild-
type levels). This compares with the far more significant reduction in MCC levels observed in
themps1-kd cells.
Having detected only subtle MCC assembly defects inmad3-C9A and mad3-C9A
mad2-S92A, we wanted to test the ability of the mutant MCC produced to bind to APC/C. These
C-terminal phosphorylation sites lie close to the second KEN box in Mad3p (KEN2), which has
been argued to be important for APC/C interactions in vertebrate cells [57]. Our previous work
has shown that the first Mad3p KEN box (KEN1) is critical for Cdc20 Slp1 binding and MCC
assembly, and that whilst KEN2 is not required for MCC assembly it is needed for fission yeast
checkpoint arrest [20]. To analyse this further, we carried out cdc25 block and release time
courses and monitored APC/C binding with themad3-KENmutants. The anti-microtubule drug
carbendazim (CBZ) was added 20 minutes after cdc25 release to test whether thesemad3 alleles
could maintain a spindle checkpoint arrest. As expected, themad3-KEN1 allele displayed no
APC/C binding, for either Mad3p or Mad2p (Fig 4). Themad3-KEN2 allele displays comparable
MCC-APC/C binding to wild-type Mad3p at early time points (45 minutes), but was unable to
maintain MCC-APC/C levels or the checkpoint arrest (MCC-APC/C levels had already fallen to
~65% of wild-type levels at 60 minutes). We scored maintenance of checkpoint arrest by analys-
ing when cells exit mitosis and septated during these time courses (Fig 4C). 50–60% of cells had
septated by 2 hours inmad3Δ,mad3-KEN1 andmad3-KEN2. These findings are consistent with
KEN2 not being required for MCC assembly or initial APC/C binding (at 45 minutes), but
instead being needed to maintain APC/C binding. A vertebrate study has argued that the BubR1-
Mad3-KEN2 box can compete with securin/cyclin substrates and thereby prolong spindle check-
point delays [57]. Another, more recent study proposed the involvement of the BubR1-KEN2
box in mediating interaction of a second molecule of Cdc20Slp1, bound to APC/C [58]. This latter
model is currently being analysed in S.pombe (see Discussion).
To test whether mutation of the C-terminal Mad3p phospho-sites flanking KEN2 perturbed
MCC-APC/C binding, we carried out cdc25 (G2) block and release time courses and immuno-
precipitated the APC/C frommad3-C9Amutants. This experiment demonstrates that the
mad3-C9A and themad2-S92A alleles displayed significantly reduced APC/C binding to
Mad3p and Mad2p at 45 and 60 minutes (Fig 5A and 5B), ie. at times when rather little effect
on MCC assembly was observed (see Fig 3B). The levels of Mad2p and Mad3p bound to the
APC/C inmad3-C9A mad2-S92A were only 20% of those in wild-type at 45 and 60 minutes
(Fig 5B). Importantly, at equivalent times in mitosis their MCC levels were 70–100% of those
in wild-type cells (Fig 3B). We scored maintenance of checkpoint arrest by analysing when
cells exit mitosis and septated during such time courses (Fig 5C). Themad2-S92A and
mad3-C9A strains both septate ahead of wild-type, and the double mutant is even more
advanced although not quite as fast as themps1-kd strain (see S5 Fig for representative images
and a direct comparison with themad3-KENmutants).
These data strongly support a model in which Mps1Mph1-dependent phosphorylation of
both Mad2p and Mad3p are required to stabilise their APC/C binding and thus to maintain
the MCC-APC/C complex and spindle checkpoint arrest.
Fig 3. MCC assembly defects are rather minor in themad3-C9A andmad2mad3 double phospho-mutants when compared tomps1-kd. A. The
cdc25 strains indicated were pre-synchronised in G2 by shifting to 36°C for 3.5 hours. They were then released at 25°C and time points taken every 15
minutes. Native extracts were made and Cdc20Slp1 was immunoprecipitated with anti-Flag antibodies. Immunopreciptates were separated by SDS-PAGE
and immunoblotted for Cdc20Slp1, Mad3p (anti-GFP) and Mad2p. B. These immunoblots were quantitated and plotted as the intensity of Mad3 or Mad2
relative to the Cdc20Slp1 level at each time point (45 and 60 minutes after release into mitosis). All values were then compared to wild-type–see Materials and
Methods for details. C. Cell cycle progression was scored by DAPI staining methanol fixed cells and quantifying the % of bi-nucleate cells in the population at
each time point (200 cells were scored at each time point).
doi:10.1371/journal.pgen.1005834.g003
Mps1Mph1 Kinase Phosphorylates Mad3
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In vitro reconstitution confirms a direct role for Mad3p phosphorylation in
APC/C inhibition
Phosphorylation of Mad3p does not appear to regulate its kinetochore targeting (Fig 2A) or
assembly into MCC (Fig 3). Even so, the effects we have observed on MCC-APC/C interactions
(Fig 5) and checkpoint arrest (Fig 2B–2D) could be indirect consequences of a defective
upstream signalling event. To confirm that Mad3p modification has a direct role in APC/C
inhibition we developed an in vitro APC/C assay, based on those previously described for both
budding and fission yeasts (see Materials and Methods, [59,60,61]). Fig 6 demonstrates that
recombinant fission yeast Mad3p can directly inhibit in vitro Cdc20Slp1-APC/C activity: as the
concentration of recombinant Mad3p was increased, a corresponding decrease in Cdc20 Slp1-
APC/C dependent ubiquitination of the radio-labelled securinCut2 substrate was observed.
Note this experiment was performed in the presence of Mad2p. Recombinant Mad3p inhibited
APC/C activity on its own, but was approximately 30% less potent than the Mad3p-Mad2p
combination. To test the effects of Mad3p phosphorylation on APC/C activity, we made a
Fig 4. mad3-KENmutants have APC/C binding defects. A. The cdc25 strains indicated were pre-synchronised in G2 by shifting to 36°C for 3.5 hours.
They were then released at 25°C and time points taken every 15 minutes. The anti-microtubule drug carbendazim (CBZ) was added after 20 minutes.
Extracts were made, Apc4-TAP pulled down with IgG Dynabeads, separated by SDS-PAGE and immunoblotted for associated Mad3p and Mad2p. B. The
immunoblots were quantitated for Mad3p and Mad2p levels, normalised to Apc4p levels, and then plotted relative to the wild-type levels at the 45 and 60
minute time points (after release into mitosis). C. At each time point cells were fixed in 100%methanol and later stained with DAPI and calcofluor to score
septation (200–300 cells were scored per sample, per time point). Septation indicates a failure to maintain the spindle checkpoint arrest.
doi:10.1371/journal.pgen.1005834.g004
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series of mutants containing phospho-mimics (S/D and/or T/E substitutions). These phos-
phorylation sites are in close proximity to the KEN2 box, suggested to be important for
Mad3p-APC/C interaction and/or competing with substrates for APC/C binding (Fig 6A). We
analysed their ability to directly inhibit Cdc20Slp1-APC/C activity in vitro (Fig 6B and 6C). The
mad3-double KENmutant protein (KEN1,2-AAA) was used here as a negative control. This
experiment was repeated three times and Fig 6C shows quantitation of the combined data.
These experiments demonstrate that the Mad3 phosphomimics are better in vitro APC/C
inhibitors than the recombinant wild-type Mad3 protein and that they display a graded
increase in potency (c.f. 0,3,4 and 7 phospho-mimicking D/E residues). We conclude that
mimicking phosphorylation of Mad3p near its C-terminal KEN2 box can directly improve its
ability to inhibit Cdc20Slp1-APC/C activity.
Mad3 phospho-mimics are not sufficient for APC/C inhibition in vivo
To test whether Mad3p modification is sufficient to induce a mitotic delay in vivo, we replaced
wild-typemad3 with alleles expressing 3, 4, 6 or 7D/E residues. These alleles produce stable pro-
teins (see S7A Fig) that can be targeted to kinetochores in an apparently normal manner (S7B
Fig). We released these strains from a cdc25-ts (G2) block into a synchronous mitosis, but no sig-
nificant metaphase delay was observed. Further studies demonstrate that themad3-3D/E and -4D/
E alleles perform as well as wild-type in other checkpoint assays, but that they do not act as gain-
of-function alleles (see S7C and S7D Fig for further details). Thus we conclude that such Mad3p
modifications are not sufficient to induce and maintain a spindle checkpoint delay in cells.
Discussion
Here we have identified Mad3p as an important substrate for Mps1Mph1 kinase, and demon-
strated that its C-terminal modification is required for maintenance of spindle checkpoint arrests
in response to microtubule (tubulin mutants or CBZ treatment, [Fig 2C and 2D and Fig 5]) and
kinetochore defects (nuf2-3 delays [Fig 2C]). In addition, our analysis ofmad3-C9A,mad2-S92A
double mutants (Figs 2, 3 and 5) suggests that Mps1Mph1 kinase modifies both Mad3p and
Mad2p, and that these act in a concerted fashion to maintain robust inhibition of APC/C. In
vitro ubiquitination assays confirm that modified forms of Mad3p (phospho-mimics) are more
potent APC/C inhibitors than the unmodified protein. We propose that phosphorylation of the
Mad3p C-terminus, in concert with Mad2p modification, stabilises its interactions with APC/C
and thereby enhances the ability of MCC to inhibit APC/C and delay anaphase onset.
These studies have highlighted the fact that Mps1 Mph1 kinase has multiple roles to play in
spindle checkpoint signalling. Its activation at kinetochores may initiate the spindle checkpoint
response [62] and several studies demonstrate that KNL1 is an important target. Once phos-
phorylated KNL1 recruits the Bub1-Bub3-Mad3 module [37,38]. Then Mps1Mph1 kinase
phosphorylates Bub1p to stabilise a Mad1p interaction, at least in budding yeast [45]. This
Bub1p-Mad1p complex may then be able to catalyse the formation of MCC [6,63]. However,
we have shown here that this is not all that Mps1Mph1 kinase does in the checkpoint, as both
Mad3p and Mad2p also need to be phosphorylated by Mps1Mph1 for cells to efficiently
Fig 5. mad3 andmad2 phospho-mutants fail to maintain stable MCC-APC/C complexes. A. The cdc25 strains indicated were pre-synchronised in G2
by shifting to 36°C for 3.5 hours. They were then released at 25°C and time points taken every 15 minutes. Carbendazim (CBZ) was added after 20 minutes.
Extracts were made, Apc4-TAP pulled down with IgG Dynabeads, separated by SDS-PAGE and immunoblotted for associated Mad3p and Mad2p. B. The
immunoblots were quantitated for Mad3p and Mad2p levels, normalised to Apc4p levels, and then plotted relative to the wild-type levels at the 45 and 60
minute time points (after release into mitosis). Plotted as mean with standard deviation (n = 2 experiments). C. Methanol-fixed cells were stained with
calcofluor and scored for septation, indicating a failure to maintain spindle checkpoint arrest. This experiment was repeated twice and >100 cells scored for
each strain at each time point. Plotted as mean with SEM.
doi:10.1371/journal.pgen.1005834.g005
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Fig 6. Mad3pmodification directly affects its ability to inhibit APC/C activity. A. Mad3p C-terminal sequence highlighting the residues mutated in the 3,
4 and 7D/E mutants. B. Fission yeast APC/C in vitro activity reactions showing the ubiquitination of securinCut2. Half of each reaction (10 μl) was taken
immediately after mixing all the components and added to 4xSDS gel buffer (0 min). The remaining 10 μl were incubated at 23°C for 45 min. Control
reactions, one lacking the activator Cdc20Slp1 (-Cdc20), one lacking the APC/C (-APC/C) and one containing both Cdc20Slp1 and APC/C (+APC/C), are
shown together with wild-type Mad3p (WT), the double KEN box mutant (mad3-KEN1,2-AAA) and the corresponding phospho-mimic mutants at 1:20 and
1:100 APC/C:Mad3p molar ratios respectively. Purified cMad2p was added at 1:12.5 APC/C:Mad2p molar ratio in all reactions. A phosphoimager and
Imagequant software were used to quantify the amount of radioactivity left in the un-modified securin band (*). C. Quantification of APC/C inhibition by wild-
type (WT) Mad3p and mutants. Results from three independent experiments were combined and plotted (as mean with SEM). Data were normalised against
APC/C activity containing no Mad2p or Mad3p (+APC/C).
doi:10.1371/journal.pgen.1005834.g006
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maintain APC/C inhibition and spindle checkpoint arrest. Thus Mps1Mph1 kinase has key roles
to play in both the establishment and maintenance of spindle checkpoint arrests.
Phosphorylation of Mad3/BubR1
The Mad3/BubR1 protein is a target of many mitotic kinases. Budding yeast Mad3p is a target
of both PoloCdc5 [64] and Aurora BIpl1 kinases [65], the latter being required for cells to
respond to lack of tension at kinetochores. In Drosophila it was reported that Polo promotes
Mps1Mph1 kinetochore localisation and that this is required for BubR1 phosphorylation and
stable MCC production [66]. In Xenopus egg extracts BubR1 is phosphorylated by Plx1, gener-
ating the 3F3/2 epitope, and this is required for checkpoint arrest [67]. However, in human
cells BubR1 phosphorylation by Plk1 was shown to be important for regulating the stability of
kinetochore-microtubule attachments [68]. The C-terminal KARD domain in BubR1, not
present in yeast Mad3, is modified by both Polo and CDK kinases and this modification regu-
lates recruitment of PP2A regulatory sub-units to kinetochores [69]. Once there, PP2A can
oppose the action(s) of Aurora B and play a part in the onset of mitotic exit. Thus Mad3/
BubR1 is a highly regulated phospho-protein, consistent with it being a key regulator of mitotic
progression. However, the specific kinases involved and the mechanistic roles of Mad3/BubR1
phosphorylation vary between model systems.
Here we have demonstrated that fission yeast Mad3p is modified by several mitotic kinases:
Mps1Mph1 and most likely CDK and AuroraArk1. Our studies indicate that the C-terminal
Mps1Mph1 sites flanking the Mad3p KEN2 box are particularly important, and that their modi-
fication can enhance the ability of this checkpoint protein to bind to and inhibit Cdc20Slp1-
APC/C. Our in vivo studies of the phospho-mimic mutants (see S7 Fig) argue that these C-ter-
minal Mad3p modifications are not sufficient to stabilise MCC-APC/C binding enough to
induce a dominant mitotic delay. We propose that additional modifications, perhaps on
Mad2p, Cdc20Slp1 or APC/C subunits would be needed to generate such a gain-of-function
phenotype in vivo. In addition, cells probably have multiple checkpoint silencing pathways, not
all of which would necessarily involve de-phosphorylation.
Combinatorial control of MCC action
In addition to the C-terminus of Mad3p (this study), Mad2p (here and [39,70]) and Cdc20Slp1
[13,71,72] are phosphorylated and their modification is also thought to ensure efficient APC/C
inhibition. Figs 2 and 5 demonstrate the synthetic defect of mutating Mad3p and Mad2p phos-
phorylation sites. Whilst the crystal structure of fission yeast MCC beautifully demonstrated the
importance of the N-terminal KEN box and conserved TPR domain in MCC formation [18],
this structure lacked the N-terminus of Cdc20Slp1 and the C-terminus of Mad3p. Both of these
apparently unstructured regions are post-translationally modified and both are critical for in vivo
regulation of Cdc20Slp1-APC/C activity (our study and [72]). It has recently been suggested that a
second molecule of vertebrate Cdc20Slp1 might be involved inMCC-Cdc20Slp1-APC/C complexes
[58]. We are currently assessing this model in fission yeast cells, but it is clear that further struc-
tural analyses employing recombinant, full-length Cdc20Slp1(s) and Mad3p will be needed before
MCC interactions with Cdc20Slp1-APC/C can be fully understood.
Materials and Methods
Generation of Mad3 phosphorylation mutants
Phosphorylation mutants were created from pJK-Mad3, which is based on the vector pJK148
[73]. It contains 500 bp of 5’UTR, followed by themad3 ORF and 500 bp of 3’UTR. Allmad3
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strains were generated by integration of pJK-Mad3 vectors into amad3Δ strain at the endoge-
nousmad3 locus. Mad3 gene synthesis (GeneArt) was used to generate the 18A allele (see Fig
1). The C9A and N9A alleles were created from the 18A vector by sub-cloning, using an Xho1
site present in the Mad3 gene. All other point mutations were introduced using the Quikchange
Kit for Site Directed Mutagenesis (Stratagene). For the APC/C binding assays C-terminal GFP
tags were introduced using the Bahler cassette system (Bahler et al. 1998)
Recombinant wild-type (wt) and phospho-mimic Mad3 mutants as well as the closed Mad2
mutant (cMad2 [39]) used for the APC/C activity assays were constructed via Gateway cloning
using the donor vector pDONR201 (Life technologies) and the destination vector pHMGWA
described previously [74] containing 6xHis and Maltose Binding Protein (MBP) tags. Proteins
were expressed in BL21 RIL cells with 0.25 mM IPTG at 18°C for 16hrs. Cells were harvested
by centrifugation and pellets were frozen at -20°C until further use. Cells were lysed by sonica-
tion in lysis buffer A containing 50 mM potassium phosphate pH 7.0, 300 mMNaCl, 5% glyc-
erol, 1mM DTT and 1% glucose supplemented with 1 mM Pefabloc (SIGMA Aldrich) and a
cocktail protease inhibitor tablet (Roche). cMad2 and Mad3 proteins were affinity purified
using amylose beads (NEB) and eluted with buffer A containing 15 mMmaltose. Eluted frac-
tions were pooled together and further purified by size exclusion chromatography using a
Superdex S200 column (GE Healthcare) either in buffer B (for cMad2) containing 25 mM
HEPES pH 7.5, 150 mMNaCl, or in buffer C (for Mad3 proteins) containing 25 mM potassium
phosphate pH 7.0, 200 mMNaCl, 5% glycerol, 1mM DTT, 1% glucose and 1 mg/ml NVOY
polymer (Expedeon). Protein purity was visualised by SDS-PAGE.
Cdc20Slp1 FLAG tagging
First, the 3’ UTR of the Slp1Cdc20 gene (460 base pairs downstream of the stop codon) was
marked with the Hygromycin B resistance gene through PCR based gene modification in yeast.
Then the genomic DNA of the Slp1Cdc20 gene with this inserted Hyg B resistance marker was
amplified by PCR and cloned into the Gateway1 pDONR 201 vector (Life Technologies). A 5’
fragment of the Slp1Cdc20 gene (the first 450 base pairs), with an insertion of three tandem cop-
ies of the FLAG-tag between nucleotides 191 and 192, was commercially synthesised (Gen-
eart1 Life Technologies) and then cloned into the Slp1Cdc20 gene in the vector. The final
construct was then linearised and used to transform haploid wild type yeast cells. Transfor-
mants were selected through their Hygromycin B resistance, and correct integration was
confirmed by PCR and DNA sequencing. FLAG-Slp1Cdc20 expression was confirmed by
immunoblotting.
Fission yeast strains
Yeasts strains are listed in S1 Table.
Mitotic arrests
For nuf2-3 arrests, cells were grown overnight in YES medium at 25°C to mid-log phase and
then shifted to 32°C for 4 hrs followed by fixation at -20°C in 100% methanol. For microscopy,
cells were mounted with 20 μg/ml DAPI (Sigma).
nda3-KM311(cs) cells were grown overnight in yeast extract plus supplements (YES)
medium at 30°C to mid-log phase and then shifted to 18°C for 6 hrs.
Preparation of the anti-microtubule drug carbendazim (CBZ). A carbendazim stock
solution (3.75 mg/ml) was prepared by dissolving it in DMSO. This solution was vortexed and
heated in a 55°C water bath, either for 1 hr (for 65 μg/ml [Fig 2]) or 3 hrs (for 75 μg/ml [Fig
5]). Then it was vortexed again and cooled down to room temperature before use.
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G2 arrests (cdc25-22) for synchronous mitotic analyses and CBZ challenge. cdc25-22
cells were grown overnight in YES medium at 25°C to mid-log phase and then shifted to 36°C
for 3.5 hrs to arrest cells in G2. To release into mitosis, cultures were rapidly cooled down to
25°C in iced-water and then incubated at 25°C for the experimental time course. 20 mins after
the G2 release into mitosis, the CBZ solution was spun at room temperature for 1 min at 4500
rpm, and the soluble phase added to liquid cultures at 65 or 75 μg/ml final concentration.
Benomyl sensitivity assay
10-fold serial dilutions were plated on YES plates containing 0, 7, 8.5 μg/ml of the microtubule
depolymerising drug benomyl. Plates were incubated at 30°C for 3 days before images were
taken.
Immunostaining
10–50 ml of overnight culture were harvested and then fixed with -80°C cold methanol and
washed twice with PEM (100 mM PIPES, pH 7.6, 1 mMMgSO4, 1 mM EGTA). Cell walls were
then digested in PEMS (PEM, 1 M sorbitol) with 0.4 mg/ml Zymolyase (MP Bio-medicals) for
30–45 min. Cells were then sequentially washed once with PEMS, PEMS-TritonX-100 (1%)
and PEM. Cells were blocked with PEMBAL (1% BSA, 0.1% L-Lysine in PEM) for 1 h and then
incubated overnight with TAT1 (mouse anti-tubulin) antibody (1:50) (kindly provided by
Keith Gull, Oxford, UK). Cells were washed once with PEM and then incubated with anti-
mouse secondary antibody (Alexa Fluor–Molecular Probes) at 1:1000 for 1 h. Mitotic spindles
were visualized using an Intelligent Imaging Innovations Marianas microscope (Zeiss Axiovert
200M, using a x100 1.3NA objective lens), CoolSnap CCD, and Slidebook software (Intelligent
Imaging Innovations, Inc., Boulder, CO).
Immunoprecipitations
Anaphase promoting complex interaction. Cells expressing TAP-tagged Lid1 (Apc4)
(original strain kindly provided by Kathy Gould, Vanderbilt, USA) and Mad2p and Mad3p
tagged with GFP from their endogenous loci were pre-synchronised in G2 via the cdc25-22
mutation. Proteins were extracted in lysis buffer (50 mMHEPES pH 7.5, 75 mM KCl, 1 mM
MgCl2, 1 mM EGTA, 0.1% TritonX-100, 1 mM sodium vanadate, 0.1 μMmicrocystin, 10 μg/
ml LPC (leupeptin/pepstatin/chymostatin) and 1 mM pefabloc). Cells were resuspended in
lysis buffer and bead-beat twice for 20 seconds. Extracts were incubated for 30 min with IgG-
coupled Dynabeads (Invitrogen), which bind to Apc4-TAP. The immunoprecipitated com-
plexes were washed three times with lysis buffer and then analysed by immunoblotting with
sheep anti-GFP antibody and sheep anti-Mad2 antibody.
MCC immunoprecipitation. Cdc20Slp1-FLAG was immunoprecipitated as above,
but using anti-FLAG (M2, Sigma) antibodies that had been pre-coupled to Dynabeads
(Invitrogen).
Quantitation of relative levels of MCC complexes:
For each strain and time point an equivalent cell pellet was lysed using the same volume of
glass beads and lysis buffer per sample. All samples for any figure panel were processed at the
same time and the full set of IPs were run on gels in parallel (whole cell lysates were typically
run the following day). eg. membrane organisation for Fig 3: wild-type &mad3-C9A IPs were
on one membrane,mad2-S92A &mad3-C9A mad2-S92A IPs on another,mps1-kd on a third.
The input lysates were run and transferred to membranes as for the IPs.
Membranes for all IP samples were incubated with primary antibody, then secondary anti-
body and then HRP substrate at the same time. These incubations (eg. anti-FLAG) were carried
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out in the same box for all 3 membranes. Note, the same membrane was first probed with anti-
FLAG (Cdc20Slp1) and anti-Mad2, then stripped and re-probed with anti-GFP (Mad3), so one
pipetted IP sample was being analysed for all 3 proteins.
For each antibody all of the membranes were exposed at the same time to a single piece of
film for each exposure. The exposure times used gave signal intensities within the linear range,
as determined by serial dilution of lysates. Relatively short exposures were used to avoid satura-
tion (e.g. 60 secs for anti-FLAG and for anti-Mad2). Band intensities were measured using
ImageJ and corrected for background. Where relevant, degradation products were combined in
the quantification (we also quantified the 2 bands separately, and this essentially gave the same
result).
The relative level of an MCC sub-unit in the complex, compared to that of the immunopre-
cipitated protein (FLAG-tagged Cdc20) were then determined for the 45 and 60 minute time
points for each strain, as these time points are before cells exit mitosis and Cdc20 levels drop.
Eg.
Mad2 ðor Mad3Þ band intensity
Cdc20Slp1 band intensity
¼ relative intensity of Mad2 ðor Mad3Þ
Then we calculated the relative level of each sub-unit in the mutant compared to that in the
wild-type strain:
Relative Mad2 ðor Mad3Þ intensity in the mutant
Relative Mad2 ðor Mad3Þ intensity in WT
and ﬁnally this was plotted as a % (eg. Fig 3B). Similar calculations were performed to deter-
mine the relative abilities of strains to formMCC-APC/C complexes, by comparing the levels
of Mad2 and Mad3-GFP in Apc4-TAP pull downs (Fig 5). Error bars represent the mean with
standard deviation.
Mps1Mph1-SZZ kinase purification. Cycling cells expressing Mph1-SZZ were pelleted,
washed once with ice-cold water, frozen and ground in liquid nitrogen. The frozen cell powder
was resuspended 2 x Hyman lysis buffer (100 mM Bis-Tris propane, 200 mM KCl, 10 mM
EGTA, 10 mM EDTA, 20% glycerol, 1% TritonX-100 supplemented with protease inhibitors
(1 mM pefabloc, 10 μg/ml leupeptin/pepstatin/chymostatin), and sonicated for 30 sec. Lysed
cells were centrifuged at 4°C for 10 min at 3000 g to remove cell debris. The remaining super-
natant was then sequentially filtered through a 2.6 μm and a 1.6 μm syringe filter. The clarified
lysate was incubated with IgG-coupled dynabeads (Invitrogen) for 30 min at 4°C. Beads were
washed three times with 1 x Hyman buffer and then three times with 1 x Hyman buffer (+ 1
mMDTT and 0.1% Tween-20). Bound proteins were eluted by incubating the beads with
100 units AcTEV protease (Invitrogen) overnight at 4°C. The supernatant was then transferred
to a new tube and the IgG-coupled Dynabeads washed once with 1 ml 1 x Hyman buffer (+ 1
mMDTT, 0.1% Tween-20). The fractions containing the eluted proteins were combined and
incubated with S-protein agarose beads (Novagen) for 3 hrs at 4°C. S-protein agarose beads
bound to Mph1-SZZ were then washed five times with 1 x Hyman buffer and frozen at -80°C
until further use.
In vitro kinase assay
Purified Mps1Mph1 kinase coupled to S-protein agarose beads was washed twice with 1 x kinase
buffer (50 mMHepes pH 7.5, 10 mMMgCl2, 0.5 mM DTT). 25 μl of kinase reaction buffer
(12.5 μl 2x kinase buffer (100 mMHepes, pH7.5, 20 mMMgCl2, 1 mMDTT), 0.5 μl P
32
gamma-ATP, 0.5 μl 1 mM ATP, made up with substrate in a final volume of 25 μl was then
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added to the beads. Reactions were typically carried out with 1.5 μg of substrate/recombinant
protein. The reaction was incubated at 30°C for 30 minutes. Cold kinase assays were carried
out with 100 mM ATP and further analysed by mass spectrometry.
Mass-spectrometry
Protein digestion and Phosphopeptide enrichment. Proteins were electrophoresed into
Novex NuPAGE 4–12% Bis-Tris gels (Invitrogen) and visualised with colloidal blue staining
kit (Invitrogen). Proteins were excised, reduced/alkylated and in-gel digested using trypsin as
described previously [75]. Peptides for direct MS analysis were desalted using C18 StageTips
[76]. Peptides for phosphopeptide enrichment were extracted from the gel using 3% TFA/30%
ACN followed by 100% ACN. Before enrichment approximately 3 mg TiO2 beads were pre-
incubated in 20 μl of 85 mg/ml lactic acid in 80% ACN/0.1%TFA. This pre-incubated bead
mixture was added to the peptide mixture and incubated for 1 h at room temperature [77].
After washing once with 10% ACN/0.1% TFA, and twice with 80% ACN/0.1% TFA, peptides
were eluted with 2% ammonium hydroxide in 40% ACN (pH 10.5). Eluate was concentrated to
100 μl and 100 μl of 2% TFA was added and peptides desalted using C18 StageTips.
Nano-LC-MS/MS and data analysis
Peptides were loaded onto a column needle self-packed [78] with ReproSil-Pur C18-AQ mate-
rial (3 μm, Dr. Maisch, Germany) at a flow rate of 0.7 μl/min. Peptides were separated using an
Aligent 1100 binary nanopump LC, with HTC Pal Auto sampler (CTC), using either a two-
step linear gradient of 0%-20% B in 35 min, 20%-80% B in 4 min and 80% B for 2 min or a
two-step linear gradient of 0%-20% B in 75 min, 20%-80% B in 13 min and 80% for 10 min
(Mobile phases were (A) 5% acetonitrile, 0.5% acetic acid and (B) 99.5% acetonitrile, 0.5% ace-
tic acid). Peptides were eluted into an LTQ-Orbitrap mass spectrometer (Thermo Fisher Scien-
tific) using a flow rate of 300 nl/min and a spray voltage of 1.8kV.
Database searching
DTAsupercharge (V1.18) was used to create peak lists from raw data. Peak lists were then used
within Mascot daemon (V2.2.0) to search against the UniProt/SwissProt Schizosaccharomyces
pombe database. Search parameters were set to: precursor mass tolerance of 10 ppm, fragment
ion mass tolerance to 0.8 Da, enzyme as trypsin, allowing 3 missed cleavages. Carboamido-
methylation of cysteine was set as a fixed modification, with oxidation of methionines, phos-
phorylation of serine, threonine, and tyrosine as variable modifications.
Large scale yeast Mad3-SZZ and Lid1/Apc4-ZZ pull downs and MudPIT
Six litres of yeast cells were grown at 30°C in concentrated rich medium to high densities that
could still support active proliferation and mitotic arrests. Mitotically arrested cells (harbouring
cold-sensitive β-tubulin alleles) were obtained by rapid cooling on iced-water and shifting cul-
tures to 18°C for 7 hours. Cells were harvested by centrifugation at 3,500g for 8 minutes at 4°C.
Pelleted cells were frozen into pea-sized drops using liquid nitrogen and stored at -80°C until
further processing. Approximately 25 g of cell mass was disrupted using a mixing mill (MM
400; Retsch, Germany) with grinding balls under cryogenic conditions (5 cycles of 3 minutes at
30 Hz). Yeast lysates were reconstituted in lysis buffer A containing 50mM Bis-Tris Propane-
HCl pH 7.6, 10% (v/v) glycerol, 100 mM KCl, 5 mM EGTA and 1% Triton X100 supplemented
with a ‘complete EDTA-free protease inhibitor’ tablet (per 50 ml), 1mM Pefabloc SC, 10 μg/
mL leupeptin/pepstatin/chymostatin (all from Roche), 20 mM β-glycerophosphate, 5mM
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NaN3, 0.4 mMNa3VO4 and 2 μMmicrocystin-LR (Axxora Life Sciences, CA, USA). Following
further lysis, by sonication, cell debris was pelleted at 4,000g for 5 min at 4°C and the superna-
tant was filtered through a 1.6 μm syringe filter. Proteins were bound to IgG-Dynabeads by
incubating the cleared lysates for 20 min at 4°C (1 mg IgG-Dynabeads per 1 g of cell input)
whilst mixing. Dynabeads with bound proteins were then washed four times with buffer A and
twice with buffer B [50 mMHEPES-KOH pH 7.0, 50 mM KCl].
Elution and precipitation of protein complexes
Proteins were eluted from Dynabeads by two x 5 min incubations with 150 μl of 100mM gly-
cine-HCl (pH 2.5) at room temperature and precipitated with 100 μl of cold 100% (w/v) tri-
chloroacetic acid. Proteins were pelleted at 4°C by centrifugation for 30 min at 22,000g.
Supernatant was removed and pellets were washed twice with 500 μl of ice-cold acetone. and
air-dried.
LC/LC-MS/MS
Proteins were reduced, alkylated and digested with trypsin. Peptides were pressure vessel
loaded onto a biphasic (C18-SCX) column. Peptides were separated by MuDPIT (Washburn
et al., 2001) using an Aligent 1100 quaternery LC with a 1:1000 split flow system. Peptides were
eluted into an LTQ mass spectrometer (Thermo Fisher Scientific) at spray voltage of 2.6 kV.
Eight data-dependant ms/ms were collected per primary scan. MS3 scans were triggered with
neutral loss values of 32.50, 49.00 and 98.00.
APC/C ubiquitination assays
Fission yeast genes E1 (Uba1) and E2s (Ubc1, 4 and 11) inserted in pMAL and pET16b plas-
mids respectively were kindly provided by Hiro Yamano (Ors et al., 2009). These were used to
recombinantly express proteins in BL21 RIL cells as described above for the Mad3 constructs.
MBP-Uba1 and His-tagged E2s were then affinity purified using either amylose (NEB) or talon
resin (Clonetech). MBP-Uba1 was subjected to further purification by size exclusion chroma-
tography using a Sephadex S200 column. Full-length APC/C activator Cdc20 Slp1 and radiola-
belled [Met S35] APC/C substrate, Securincut2 were generated by in vitro translation using the
TNT Quick Coupled Transcription/Translation kit (Promega) according to manufacturer’s
instructions using 1μg of pHY22-Cdc20Slp1 and pHY22-Securincut2 plasmids also provided by
Hiro Yamano. Lid1-TAP APC/C was affinity purified using IgG agarose beads (GE Healthcare)
as previously described [59,79] from S. pombe cells carrying the ts slp1-362mutation [80] to
allow the isolation of the APC/C free from endogenous Cdc20slp1.
In vitro APC/C ubiquitination assays were performed following a method based on assays
previously described for budding, fission yeast and human proteins [59,61,81]. In brief, 0.05
mg/ml Uba1, 0.5mg/ml E2s (ubc1, ubc4 and ubc11) and 0.3 mM ATP were mixed with 1.5 mg/
ml wild-type mono-ubiquitin (Sigma Aldrich), 2μM ubiquitin aldehyde (Boston Biochem) in a
ubiquitination buffer containing 25 mMHEPES pH 7.5, 100 mM KCl, 3mM ATP, 2.5 mM
MgCl2, and 0.2 mM DTT. The ubiquitination mix was incubated at 23°C for 20 min. 0.5 μM
APC/C, 4 ul and 2 ul of Cdc20Slp1 and SecurinCut2 respectively were then added to the mix in a
total reaction volume of 20 μl. Reactions were carried out at 23°C for 45 min and stopped by
adding 4xSDS gel buffer. Samples were subjected to SDS-PAGE electrophoresis and visualised
by radiography using the Typhoon phosphoimager. The ubiquitination of SecurinCut2 by APC/
C was analysed using the ImageQuant software (GE Healthcare) by quantifying the decrease in
intensity of the unmodified Securin band (labelled “Securin” in Fig 6B). The ability of Mad3
and phospho-mimic mutants to inhibit the activity of APC/C was assessed by pre-incubating
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APC/C, Cdc20Slp1 and cMad2 with the corresponding Mad3 protein at 4°C for 30 min prior to
adding them to the ubiquitination mix.
Supporting Information
S1 Fig. (A) Fission yeast Mad3p alignments. These fission yeast sequences are available at
the Broad Institute (MIT, Harvard). The two sets of mutations (generating N9A and C9A) are
highlighted on the S. pombe sequence with red boxes. T82 (a putative Aurora site) is in green.
(B) Phosphosites identified. The superscript indicates the number with number of unique spec-
tra/peptides in which the phosphorylated residue was identified. The residues highlighted in
red (identified in vitro and confirmed in vivo) were only observed in mitotic samples.
(PDF)
S2 Fig. Example spectra for Mad3 T259, T278 and S279. These serve as examples of MS/MS
spectra used to identify and assign phosphorylation of peptides. Fragment ions containing the
peptide’s N- (b-ions) or C- (y-ions) termini are labelled. A number of the identified peptides
show neutral loss of phosphoric acid from the full-length peptide, supporting the conclusion of
peptide phosphorylation. Significant fragmentation has also occurred allowing peptide
sequencing and assignment of the phosphorylated residue.
(PDF)
S3 Fig.mad3-S289A is not sensitive to anti-microtubule drugs. (A) Strains were plated on
rich (YES) media containing the indicated concentrations of the microtubule disrupting drug
benomyl, and grown at 30°C for 3 days. (B) cdc25 strains containing wild-typemad3, or
mad3-S289A, ormps1-kdmutations were synchronised in G2, released in mitosis and then
challenged to arrest in response to 75μg/ml of the anti-microtubule drug carbendazim (CBZ).
Failure to maintain mitotic checkpoint arrest leads to septation. This was scored at 15 minute
time-intervals, by methanol-fixing cells and staining with calcofluor. Themad3-S289A allele
behaved like wild-type.
(PDF)
S4 Fig. Septation ofmad3 phosphomutants indicates defects in maintenance of spindle
checkpoint arrest. (A) cdc25 strains containingmad3-C9A,mad2-S92A,mad3-C9A and
mad2-S92A, ormps1-kdmutations and GFP-tagged Mad3 were synchronised in G2, released
in mitosis and then challenged to arrest in response to the anti-microtubule drug carbendazim
(CBZ). Failure to maintain mitotic checkpoint arrest leads to septation. This was scored at 15
minute time-intervals, by methanol-fixing cells and staining with calcofluor. These images are
from the 60 minute time-point and accompany the experiment presented in Fig 2D. The scale
bar is 5 microns. (B) In some of themad3-C9A cells the Mad3-GFP can still be detected on
kinetochores after cells have septated. This observation is consistent with such cells failing to
maintain their checkpoint arrest due to a “downstream” defect in APC/C binding, rather than
a Mad3 defect in checkpoint signalling at kinetochores and/or the kinetochore attachments
being satisfied in these mutant strains.
(PDF)
S5 Fig. Septation ofmad3-KEN and phosphomutants revealing defects in the maintenance
of spindle checkpoint arrest. cdc25 strains indicated were pre-synchronised in G2 by shifting
to 36°C for 3.5 hours. They were then released at 25°C and time points taken every 15 minutes.
Carbendazim (CBZ) was added after 20 minutes. Cells containing Mad3-GFP were fixed in
methanol, stained with calcofluor and then scored for septation, which indicates a failure to
maintain spindle checkpoint arrest. The images are from the 60 min time point, and represent
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the strains used in Figs 4 and 5. The scale bar is 5 microns.
(PDF)
S6 Fig. Quantitation of Cdc20Slp1 levels in the cell extracts from Fig 3. The peak level of
Cdc20Slp1 is ~80% in themps1-kd strain when compared to wild-type in this and similar exper-
iments. This can partly account for the reduced levels of MCC inmps1-kd, but not in themad3
phospho-mutants.
(PDF)
S7 Fig. (A) The recombinant Mad3-MBP fusions are all soluble and stable. The gel shown
here was stained with coomassie. (B) Mad3 phospho-mimics are targeted to kinetochores. The
indicated strains were synchronised in G2 using the cdc25 block, and then released into mitosis
before imaging. Scale bar is 10 microns. (C) Themad3-3D/E and 4D/E phospho-mimic alleles
are not significantly benomyl sensitive, but themad3-6D/E and 7D/E alleles are sensitive.
Strains were plated on rich (YES) media containing the indicated concentrations of the micro-
tubule disrupting drug benomyl, and grown at 30°C for 3 days. (D) Themad3-3D/E and 4D/E
phospho-mimic alleles are checkpoint competent, but themad3-6D/E and 7D/E alleles are
unable to maintain an nda3 arrest. nda3 strains containing the indicatedmad3 alleles, or the
mad2 deletion as a control, were shifted to 18°C for 4 and 6 hours. Plo1-GFP, which binds
SPBs in mitosis, was used to score the mitotic index. Themad3-3D/E and -4D/E alleles arrest
well. Themad3-6D/E and -7D/E alleles initially arrest (4 hours) but are unable to maintain the
checkpoint arrest and by 6 hours have a significant defect. This indicates that having six or
more constitutive phospho-mimic mutations near KEN2 perturbs Mad3p function.
(PDF)
S1 Table. Fission yeast strain list.
(PDF)
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